title: [Efficacy of myelopid in immunodeficiency states].
authors.forename: R V
authors.initials: RV
authors.lastname: Petrov
authors.forename: A M
authors.initials: AM
authors.lastname: Borisova
authors.forename: A V
authors.initials: AV
authors.lastname: Glazko
authors.forename: A V
authors.initials: AV
authors.lastname: Simonova
authors.forename: R N
authors.initials: RN
authors.lastname: Stepanenko
mesh_terms: D028341:Activins; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000188:drug therapy*; D001402:B-Lymphocytes / Q000187:drug effects; D001991:Bronchitis / Q000276:immunology; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007958:Leukocyte Count / Q000187:drug effects; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000276:immunology; D009842:Oligopeptides; D010455:Peptides / Q000627:therapeutic use*; D011014:Pneumonia / Q000276:immunology; D012074:Remission Induction / Q000379:methods; D013601:T-Lymphocytes / Q000187:drug effects
chemical_list: D000276:Adjuvants, Immunologic; D009842:Oligopeptides; D010455:Peptides; C044147:activin B; D028341:Activins; C048617:myelopeptides
vernacular_title: Effektivnost' deĭstviia mielopida pri immunodefitsitnykh sostoianiiakh.